Influence of 1 alpha-(OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double blind controlled study

Clin Endocrinol (Oxf). 1983 Aug;19(2):265-73. doi: 10.1111/j.1365-2265.1983.tb02989.x.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism*
  • Calcium / metabolism
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Hydroxycholecalciferols / therapeutic use*
  • Liver Diseases / drug therapy
  • Lung Diseases, Obstructive / drug therapy
  • Male
  • Middle Aged
  • Minerals / metabolism*
  • Osteoporosis / drug therapy

Substances

  • Glucocorticoids
  • Hydroxycholecalciferols
  • Minerals
  • Calcium
  • alfacalcidol